September 2010 in “Hair transplant forum international” Alfonso Barrera was recognized as Surgeon of the Month.
17 citations
,
July 1977 in “International Journal of Dermatology” Proper shaving techniques and specific topical treatments can help manage pseudofolliculitis barbae.
October 2023 in “Open Repository of the University of Porto (University of Porto)”
November 2024 in “Journal of Cosmetic Dermatology” Baricitinib is effective for severe alopecia areata but has some side effects.
5 citations
,
May 2025 in “Journal of the American Academy of Dermatology” January 2025 in “Surgical & Cosmetic Dermatology” Temporal triangular alopecia causes permanent hair loss and can be managed with treatments like minoxidil or hair transplantation.
5 citations
,
April 2019 in “DOAJ (DOAJ: Directory of Open Access Journals)” Stopping shaving or removing hair follicles usually resolves Pseudofolliculitis barbae.
2 citations
,
June 2016 in “Journal of Medical Science And clinical Research” Barever Natural Hair Inhibitor can help reduce unwanted body hair growth long-term when used with waxing or hair removal cream.
January 2024 in “Journal of Clinical Images and Medical Case Reports” Baricitinib may help treat frontal fibrosing alopecia and facial papules.
August 2024 in “Journal of the American Academy of Dermatology” Baricitinib effectively promotes hair regrowth in both scalp and nonscalp areas for alopecia areata universalis patients.
June 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Baricitinib is used for severe alopecia areata after trying corticosteroids or other JAK inhibitors.
21 citations
,
February 1988 in “Toxicology” High doses of TCB cause severe health issues in marmoset monkeys.
4 citations
,
April 2005 in “UNESP Institutional Repository (São Paulo State University)” Mutamba may help treat hair loss due to its tannins and other compounds.
January 2025 in “Surgical & Cosmetic Dermatology” Histopathological confirmation is crucial to accurately diagnose alopecia triangular temporal and avoid unnecessary treatments.
November 2024 in “Journal of the European Academy of Dermatology and Venereology” Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.
October 2024 in “American Journal of Case Reports” Baricitinib improved hair loss and arthritis in a lupus patient.
December 2025 in “PubMed” Baricitinib is effective and safe for treating severe alopecia areata.
2 citations
,
January 2023 in “Skin Appendage Disorders” Beard alopecia areata causes patchy beard hair loss, often treatable with janus kinase inhibitors.
January 2026 in “Clinics and Practice” Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.
October 2024 in “Journal of the European Academy of Dermatology and Venereology” Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.
July 2023 in “International Journal of Molecular Sciences” Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.
July 2023 in “Photobiomodulation, photomedicine, and laser surgery” Photobiomodulation increased hair count in men with hair loss after 5 weeks, with no further increase after 10 weeks.
September 2025 in “Journal of Skin and Stem Cell” Baricitinib shows promise for treating various skin conditions beyond alopecia areata.
76 citations
,
February 2015 in “Industrial Crops and Products” Researchers found over 40 compounds in Bituminaria bituminosa, including many flavonoids and some with potential for medical and hair care uses.
7 citations
,
January 2022 in “Brazilian Journal of Biology” Mangabeira leaf extract is effective for making antioxidant-rich shampoos.
July 1997 in “Hair transplant forum international” The document could not be processed.
August 2018 in “Cadernos de Agroecologia” The new sulfur paste effectively treats rabbit scabies, promoting healing and hair growth.
21 citations
,
October 2023 in “Journal of Dermatological Treatment” Baricitinib effectively reduces hair loss in severe alopecia areata and is generally safe.
Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.
July 2023 in “Clinical and Experimental Dermatology” Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.